Hepatitis Monthly

Published by: Kowsar

Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study

Kamal Dumaidi 1 , * and Amer Al-Jawabreh 1 , 2
Authors Information
1 Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Arab American University, Jenin, Palestine
2 Al-Quds Public Health Society, Jerusalem, Palestine
Article information
  • Hepatitis Monthly: November 01, 2015, 15 (11); e29325
  • Published Online: November 7, 2015
  • Article Type: Research Article
  • Received: May 13, 2015
  • Revised: August 15, 2015
  • Accepted: August 29, 2015
  • DOI: 10.5812/hepatmon.29325

To Cite: Dumaidi K, Al-Jawabreh A. Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study, Hepat Mon. 2015 ; 15(11):e29325. doi: 10.5812/hepatmon.29325.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Hepatitis B fact sheet. 2012;
  • 2. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 3. Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther. 2010; 15 Suppl 3: 25-33[DOI][PubMed]
  • 4. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 5. Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005; 366(9494): 1379-84[DOI][PubMed]
  • 6. Centers for Disease C. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982; 31(24): 317-22[PubMed]
  • 7. Expanded Programme on Immunization Global Advisory Group. 1992;
  • 8. Van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board. BMJ. 1997; 314(7086): 1033-6[PubMed]
  • 9. Roznovsky L, Orsagova I, Kloudova A, Tvrdik J, Kabieszova L, Lochman I, et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection. 2010; 38(5): 395-400[DOI][PubMed]
  • 10. Poovorawan Y, Theamboonlers A, Hirsch P, Vimolket T, Sinlaparatsamee S, Chaiear K, et al. Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand. Ann Trop Med Parasitol. 2000; 94(6): 615-21[PubMed]
  • 11. Duval B, Gilca V, Boulianne N, De Wals P, Masse R, Trudeau G, et al. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J. 2005; 24(3): 213-8[PubMed]
  • 12. Kao JH, Chen DS. Hepatitis B vaccination: to boost or not to boost? Lancet. 2005; 366(9494): 1337-8[DOI][PubMed]
  • 13. Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. J Infect Dis. 1997; 175(3): 674-7[PubMed]
  • 14. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003; 187(1): 134-8[DOI][PubMed]
  • 15. Young BW, Lee SS, Lim WL, Yeoh EK. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers. J Viral Hepat. 2003; 10(1): 23-30[PubMed]
  • 16. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet. 2000; 355(9203): 561-5[PubMed]
  • 17. Recommendations of the Immunisation Practices Advisory Committee: Recommendations for protection against viral hepatitis. MMWR Morbid Mortal Wkly Rep. 1985; 34: 329-35
  • 18. Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed. 1997; 77(1)-51[PubMed]
  • 19. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1-2[PubMed]
  • 20. Palestinian Ministry of Health. Annual Health Report in Palestine-2005. . Palestinian Health Information Center (PHIC). 2006;
  • 21. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999; 179(2): 489-92[DOI][PubMed]
  • 22. Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ. Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. J Med Virol. 2007; 79(11): 1650-4[DOI][PubMed]
  • 23. Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol. 2009; 50(4): 805-16[DOI][PubMed]
  • 24. World Health Organization. . Position paper, Hepatitis B. Wkly Epidemiol Rec. 2009; 84: 405-20
  • 25. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006; 78(2): 169-77[DOI][PubMed]
  • 26. Behre U, Bleckmann G, Crasta PD, Leyssen M, Messier M, Jacquet JM, et al. Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother. 2012; 8(6): 813-8[DOI][PubMed]
  • 27. Alfaleh F, Alshehri S, Alansari S, Aljeffri M, Almazrou Y, Shaffi A, et al. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect. 2008; 57(5): 404-9[DOI][PubMed]
  • 28. Al Ghamdi SS, Fallatah HI, Fetyani DM, Al-Mughales JA, Gelaidan AT. Long-term efficacy of the hepatitis B vaccine in a high-risk group. J Med Virol. 2013; 85(9): 1518-22[DOI][PubMed]
  • 29. But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine. 2008; 26(51): 6587-91[DOI][PubMed]
  • 30. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine. 2010; 28(3): 730-6[DOI][PubMed]
  • 31. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005; 142(5): 333-41[PubMed]
  • 32. Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine. 2009; 27(47): 6613-8[DOI][PubMed]
  • 33. Norouzirad R, Shakurnia AH, Assarehzadegan MA, Serajian A, Khabazkhoob M. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran. Hepat Mon. 2014; 14(1)[DOI][PubMed]
  • 34. Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine. 2012; 30(27): 4034-9[DOI][PubMed]
  • 35. Annual Health Report- Palestine 2012 2013;
  • 36. Stein-Zamir C, Zentner G, Tallen-Gozani E, Grotto I. The Israel National Immunization Registry. Isr Med Assoc J. 2010; 12(5): 296-300[PubMed]
  • 37. Grosso G, Mistretta A, Marventano S, Ferranti R, Mauro L, Cunsolo R, et al. Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 38. Yazdanpanah B, Safari M, Yazdanpanah S. Persistence of HBV Vaccine's Protection and Response to Hepatitis B Booster Immunization in 5- to 7-Year-Old Children in the Kohgiloyeh and Boyerahmad Province, Iran. Hepat Mon. 2010; 10(1): 17-21[PubMed]
  • 39. Noubiap JJ, Nansseu JR, Kengne KK, Tchokfe Ndoula S, Agyingi LA. Occupational exposure to blood, hepatitis B vaccine knowledge and uptake among medical students in Cameroon. BMC Med Educ. 2013; 13: 148[DOI][PubMed]
  • 40. Ibrahim N, Idris A. Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University. Hepat Res Treat. 2014; 2014: 131920[DOI][PubMed]
  • 41. Pathoumthong K, Khampanisong P, Quet F, Latthaphasavang V, Souvong V, Buisson Y. Vaccination status, knowledge and awareness towards hepatitis B among students of health professions in Vientiane, Lao PDR. Vaccine. 2014; 32(39): 4993-9[DOI][PubMed]
  • 42. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States 2006;
  • 43. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009; 50(3): 661-2[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments